Podcast


Presenter: Allison Paige MD CCFP G. Michael Allan MD CCFP James McCormack BSc(Pharm) PharmD

In episode 515, James and Mike invite Allison Paige to the podcast for the first time. Alli takes us through all the evidence around a combination product (naltrexone/bupropion) for weight loss. We talk about all the numbers we have for benefit, harm and cost and we put this agent into the context of the other…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here



CFPCLearn Logo

Listening to the Podcast can earn you MainPro+ Credits

Join Now

Already a CFPCLearn Member? Log in



Latest Podcasts

BS Medicine Episode #586: It’s time to challenge penicillin allergy labels

In episode 586, Mike and James invite Émélie Braschi back to the podcast to talk about the tricky issue of how to deal with a potential penicillin allergy. Believe it…
Listen 0.5 credits available

BS Medicine Episode #585: PREMIUM – Beta-blockers after an MI and respiratory specialists for COPD

In episode 585, Mike and James finally get back to being PREMIUM. We review the REDUCE-AMI trial which tried to answer the question – do you need to use a…
Listen 0.5 credits available

BS Medicine Episode #584: Remind me, do medications that target brain amyloid improve my dementia?

In episode 584, Mike and James invite Tina Korownyk back to the podcast to talk about the evidence for amyloid-targeting monoclonal antibodies in mild cognitive impairment or Alzheimer’s dementia. Unfortunately,…
Listen 0.5 credits available

Presenter(s):

Allison Paige MD CCFP G. Michael Allan MD CCFP James McCormack BSc(Pharm) PharmD

This content is certified for MainPro+ Credits, log in to access


Presenter(s):

  • Allison Paige MD CCFP
  • G. Michael Allan MD CCFP
  • James McCormack BSc(Pharm) PharmD

Spearkers do not have any conflicts of interest to declare.